We are live on ! Find out more
FL

Fort LP Portfolio holdings

AUM $39.6M
1-Year Est. Return 37.11%
This Fund
S&P 500
This Quarter Est. Return
+7.71%
1 Year Est. Return
+37.11%
3 Year Est. Return
+56.81%
5 Year Est. Return
+128.28%
10 Year Est. Return
+343.79%
AUM
$239M
AUM Growth
+$53.9M
Cap. Flow
+$41.7M
Cap. Flow %
17.47%
Top 10 Hldgs %
6.49%
Holding
318
New
49
Increased
177
Reduced
69
Closed
23

Top Buys

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$738K
2
CI icon
Cigna
CI
+$716K
3
SLGN icon
Silgan Holdings
SLGN
+$709K
4
BIIB icon
Biogen
BIIB
+$671K
5
MOH icon
Molina Healthcare
MOH
+$671K

Sector Composition

Rank Sector Weight
1 Technology 25.16%
2 Healthcare 21.16%
3 Industrials 19.58%
4 Consumer Staples 13.33%
5 Consumer Discretionary 7.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TECH icon
151
Bio-Techne
TECH
$11.2B
$743K 0.31%
11,992
+8,264
+222% +$538K
WBD icon
152
Warner Bros
WBD
$64.6B
$742K 0.31%
34,099
+22,350
+190% +$488K
HLF icon
153
Herbalife
HLF
$1.23B
$740K 0.31%
15,865
+1,796
+13% +$88.2K
CVS icon
154
CVS Health
CVS
$137B
$722K 0.3%
12,366
+8,621
+230% +$536K
FTDR icon
155
Frontdoor
FTDR
$5.02B
$713K 0.3%
18,321
+12,540
+217% +$535K
SLGN icon
156
Silgan Holdings
SLGN
$4.91B
$711K 0.3%
+19,343
New +$709K
ORLY icon
157
O'Reilly Automotive
ORLY
$72.4B
$704K 0.3%
22,890
-690
-3% -$21K
RACE icon
158
Ferrari
RACE
$63.3B
$700K 0.29%
3,805
+528
+16% +$98.2K
WAT icon
159
Waters Corp
WAT
$36.8B
$699K 0.29%
3,573
+983
+38% +$204K
QLYS icon
160
Qualys
QLYS
$4.84B
$695K 0.29%
7,091
+5,014
+241% +$536K
CI icon
161
Cigna
CI
$76.6B
$689K 0.29%
+4,068
New +$716K
DSGX icon
162
Descartes Systems
DSGX
$5.84B
$687K 0.29%
12,065
+4,510
+60% +$250K
BIIB icon
163
Biogen
BIIB
$29.9B
$683K 0.29%
+2,407
New +$671K
MCK icon
164
McKesson
MCK
$98.5B
$677K 0.28%
4,549
+1,028
+29% +$156K
MOH icon
165
Molina Healthcare
MOH
$10.3B
$675K 0.28%
+3,689
New +$671K
CABO icon
166
Cable One
CABO
$213M
$669K 0.28%
355
-208
-37% -$377K
MMM icon
167
3M
MMM
$89B
$660K 0.28%
+4,926
New +$663K
RVTY icon
168
Revvity
RVTY
$12.3B
$649K 0.27%
+5,171
New +$594K
CAG icon
169
Conagra Brands
CAG
$7.07B
$631K 0.26%
+17,672
New +$647K
HSIC icon
170
Henry Schein
HSIC
$9.74B
$630K 0.26%
10,723
-3,022
-22% -$194K
MSM icon
171
MSC Industrial Direct
MSM
$7.02B
$630K 0.26%
+9,950
New +$660K
EXEL icon
172
Exelixis
EXEL
$13.9B
$619K 0.26%
+25,315
New +$591K
CTAS icon
173
Cintas
CTAS
$82.4B
$616K 0.26%
7,404
-4,072
-35% -$314K
NBIX icon
174
Neurocrine Biosciences
NBIX
$17.7B
$613K 0.26%
+6,378
New +$738K
GD icon
175
General Dynamics
GD
$105B
$606K 0.25%
4,380
+702
+19% +$104K

Similar funds

Fort LP's Q3 2020 Portfolio in Review

As of Q3 2020, Fort LP held 318 positions worth $239M, up 29% from $185M the previous quarter. Its ten largest holdings account for 6.5% of the portfolio.

Fort LP deployed $41.7M of net new capital in Q3 2020, opening 49 new positions and adding to 177 existing holdings. Its largest new stake was Neurocrine Biosciences: 6,378 shares worth $613K.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 25% a quarter earlier, followed by Healthcare and Industrials.

On the sell side, the largest reduction was Cable One, an estimated $377K trimmed.

  • Fort LP's largest Q3 2020 buy was Neurocrine Biosciences: 6,378 shares worth $613K.
  • Fort LP added most to Vertex Pharmaceuticals in Q3 2020, an estimated $553K increase.
  • Fort LP's biggest Q3 2020 reduction was Cable One, cutting an estimated $377K.
  • Fort LP fully exited Paramount Global Class B in Q3 2020, selling an estimated $547K.
  • Fort LP's ten largest holdings make up 6.5% of its $239M portfolio in Q3 2020.
  • Fort LP opened 49 new positions and closed 23 in Q3 2020.
  • Fort LP's portfolio value rose 29% quarter-over-quarter to $239M.

Based on Fort LP's 13F filing for Q3 2020, filed 13 Nov 2020.